The Rare Hematology Commercial Excellence Director for the US Rare Disease, Rare Hematology Therapeutic Area will be responsible for leading insights generation and innovative strategy development to maximize the business impact of our Rare Hematology portfolio. This role will be the lead for Strategic Planning by providing analytic and strategic support and optimizing field force deployment - this will include the current Rare Hematology therapeutic area as well as future launch assets. Additionally, this colleague will be the lead/coordinating stakeholder in data management, process and implementation for the customer facing functions for their Rare Disease therapeutic areas. The colleague will join a distinctive function with a demonstrated record of preparing colleagues for promoted opportunities across various functions, e.g., sales leadership, account management leadership, marketing, commercial operations, advanced analytics.
The individual should possess a combination of strategic thinking, analytical expertise, project management skills with excellent communication skills, presentation abilities and people management skills to help the Rare Disease US organization achieve aggressive patient impact and revenue targets. S/he will report directly to the US Rare Disease Commercial Effectiveness Lead and collaborate closely with respective TA marketing team, sales/account teams, BAI, payer, Medical, corporate affairs, legal, finance, external third-party vendors, operations and digital.
Key responsibilities include:
Lead Rare Hematology sales strategy
- Lead scorecard review with Rare Disease sales/account management and marketing leaders to track performance and share best practices and key insights
- Partner with Rare Disease’s Global Business Analytics (GBA), Operations/Enablement, and other Commercial Effectiveness colleagues to share and align on insights, strategies, and reporting
- Identify opportunities and gaps in strategy/ tactical execution, develop and implement solutions via frequent interactions with field-based colleagues, brand team leaders, and cross-functional partners
- Develop a Rare Disease partnership & PFE collective advantage playbook with learnings to enhance our organizational effectiveness aligned to our Bold Move 3.3 Go-To-Market Transformation
Lead Rare Hematology sales/account and commercial model planning
- Partner with the US cross-functional team to identify novel go-to-market strategy and new capabilities
- Develop new, and improve existing, processes to optimize our deployment strategy for the Rare Hematology field force, in alignment with other customer facing roles (e.g KAM)
- Evaluate on-going learnings into our BM 3.3 Go-To-Market Transformation strategy and recommend revised approaches to benefit ongoing brand performance
- Design and develop ongoing strategies for FF optimization and commercial effectiveness
Optimize field force deployment
- Partner with CE team lead to facilitate cross-functional teams to assess, design and implement deployment solutions aligned to operating plan and brand strategic priorities
- Develop tools and resources for leaders to optimize deployment based on local market dynamics, vacancies, and portfolio changes
- Proactively identify opportunities to drive innovation in our go-to-market model (structure, roles, technology and/or capabilities)
- Plan, direct and coordinate new and ongoing projects (SMART, ELEVATE) to ensure on-time completion within budget and successful deployment in collaboration with CE Team
- Connect granular task to longer-term strategic initiatives for greater RD
- Serve as a key liaison between leadership, vendors and key stakeholders
- Assist and/or manage data procurement and processing budget
- Partner with BAI/Operations/Digital/GRWD to manage data vendors, metric & business rule alignment, reporting governance and platform management
- BA/BS Degree required. MBA or other advanced professional degree (e.g., PhD, MD, JD) preferred
- 10 years of previous pharmaceutical, biotech, or medical marketing/sales/consulting experience with a strong knowledge of the pharmaceutical marketplace and deep understanding of the pharmaceutical industry, broader trends in healthcare landscape and economics.
- 2+ years of commercial analytical experience including broad background in consulting, business analytics, finance, health economics, marketing strategy or equivalent set of experiences required
- Excellent analytical skills, including strategic thinking, ability to frame problems and opportunities using supporting data, problem solving and measuring impact
- Demonstrated proficiency at leading complex multi-faceted projects and managing cross-functional teams
- A thought leader and self-starter, proactively identifying the need for specific analyses and programs, and marshaling the resources to evaluate and resolve the most challenging, strategic issues
- Demonstrated leadership skills, ability to lead change and influence without direct authority
- Ability to influence and establish good working relationships with senior executives
- Excellent communication skills, including presentations, PowerPoint/written, meeting facilitation, and one-on-one/small group
- Passion for innovation and excellence in achieving results
- Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
LAST DAY TO APPLY: 10/04/2022
Relocation assistance may be available based on business needs and/or eligibility.
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Marketing and Market Research